Kawasaki Disease and Coronary Complications
Kawasaki Disease and Coronary Complications is a research topic within Surgery. Science Explorer counts 12k research works in it since 1950. 13.8% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on Kawasaki disease, particularly its diagnosis, treatment, and long-term management. It also explores the association of Kawasaki disease with multisystem inflammatory syndrome, coronary artery abnormalities, and the impact of SARS-CoV-2 on pediatric inflammatory syndrome. The papers cover epidemiological features, immunological aspects, and treatment guidelines for this condition.
- Kawasaki Disease
- Multisystem Inflammatory Syndrome
- Coronary Artery Abnormalities
- Intravenous Immunoglobulin
- SARS-CoV-2
- Pediatric Inflammatory Syndrome
- Cardiac Manifestations
- Epidemiology
- Immunological Features
- Treatment Guidelines
- Research works
- 12k fractional, since 1950
- In the world top 10%
- 1.6k per year above
- Top-10% rate
- 13.8% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +93% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Kawasaki Disease and Coronary Complications research?
By volume, the United States and China publish the most (548 and 392 works in 2022–2025).
By volume, 2022–2025
- 1 United States 548 works
- 2 China 392 works
- 3 Japan 220 works
- 4 India 202 works
- 5 Türkiye 148 works
- 6 Italy 125 works
- 7 United Kingdom 79 works
- 8 Iran 72 works
- 9 Brazil 71 works
- 10 South Korea 58 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Kawasaki Disease and Coronary Complications research?
By volume in 2022–2025, Post Graduate Institute of Medical Education and Research publishes the most Kawasaki Disease and Coronary Complications research, followed by Sağlık Bilimleri Üniversitesi and Sichuan University.
By volume, 2022–2025
- 1 Post Graduate Institute of Medical Education and ResearchIndia 21 works
- 2 Sağlık Bilimleri ÜniversitesiTürkiye 15 works
- 3 Sichuan UniversityChina 12 works
- 4 All India Institute of Medical SciencesIndia 11 works
- 5 Tehran University of Medical SciencesIran 9 works
- 6 Hacettepe UniversityTürkiye 9 works
- 7 University of California San DiegoUnited States 8 works
- 8 Children's Hospital of PhiladelphiaUnited States 8 works
- 9 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 7 works
- 10 Kaohsiung Chang Gung Memorial HospitalTaiwan 7 works
Who are the leading researchers in Kawasaki Disease and Coronary Complications?
The most-cited researchers publishing on Kawasaki Disease and Coronary Complications include Erika Ota.
- 1 Erika Ota Japan 2.5k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Kawasaki Disease and Coronary Complications research done?
The largest centres of Kawasaki Disease and Coronary Complications research in 2022–2025 are Tokyo (Japan), Istanbul (Türkiye), Beijing (China) and Chengdu (China). Among places with at least 20 works in it, it is an unusually large share of all research in Chandigarh.
Largest cities, 2022–2025
Where it is the local speciality
- ChandigarhIN · 21.1 works7.2×
Location quotient: how much more of its research is in Kawasaki Disease and Coronary Complications than the world average.
Where is the best place to study Kawasaki Disease and Coronary Complications?
Among universities, judged by research, Post Graduate Institute of Medical Education and Research, Sağlık Bilimleri Üniversitesi and Sichuan University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Post Graduate Institute of Medical Education and ResearchIndia | 77.3 | 14.4% | 23.1× | 20 | +305.9% |
| 2 | Sağlık Bilimleri ÜniversitesiTürkiye | 54.5 | 2.6% | 9.6× | 15 | — |
| 3 | Sichuan UniversityChina | 50.3 | 20.4% | 2.6× | 12 | +300.5% |
| 4 | Tehran University of Medical SciencesIran | 49.0 | 11.7% | 7.4× | 9 | +145.3% |
| 5 | University of California San DiegoUnited States | 41.4 | 24.3% | 3.6× | 8 | +43.1% |
| 6 | Hacettepe UniversityTürkiye | 36.2 | 13.9% | 6.8× | 9 | +55.0% |
| 7 | All India Institute of Medical SciencesIndia | 35.3 | 1.0% | 6.8× | 11 | +196.9% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Kawasaki Disease and Coronary Complications research growing?
Output in 2018–2022 was 93% higher than in 2013–2017, peaking in 2021. The fastest-growing topics are Kawasaki Disease and Coronary Complications.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.